Tiotropium Inhalation Powder
RxNorm 2108544
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2108544 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: tiotropium Inhalation Powder.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
FNPrescribable
Full form of descriptor (FN):
Product containing tiotropium in pulmonary dose form (medicinal product form)
(Atom ID: 10819557)
SCDFPrescribable
Semantic Clinical Drug Form (SCDF):
Tiotropium Inhalation Powder
(Atom ID: 10788912)
PTPrescribable
Designated preferred name (PT):
Tiotropium-containing product in pulmonary dose form
(Atom ID: 10821957)
Patient Education
Tiotropium Oral Inhalation
Tiotropium is used to prevent wheezing, shortness of breath, coughing, and chest tightness in patients with chronic obstructive pulmonary disease (COPD, a group of diseases that affect the lungs and airways) such as chronic bronchitis (swelling of the air passages that lead to the lungs) and emphysema (damage to air sacs in the lungs). Tiotropium is in a class of medications called bronchodilators. It works by relaxing and opening the air passages to the lungs to make breathing easier.
[Learn More]
* Please review the disclaimer below.